Search Results

Viewing Page 2 of 20 | Showing Results 11 - 20 of 198

The Global cVAD Registry Protocol

The goal of the Global cVAD Registry is to collect clinical and procedural data retrospectively from hospital medical records for patients who...

John L. Petersen II, MD

EVOLVE Short DAPT

The EVOLVE Short DAPT Study is a prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk...

SHIELD II - Supporting Patient Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device

The HeartMate PHP System is a temporary (<6 hours) ventricular assist device indicated for use during high risk percutaneous coronary...

John L. Petersen II, MD

DECAAF II - Efficacy of DE-MRI-Guided Fibrosis Ablation vs. Conventional Ablation of Atrial Fibrillation

To examine the efficacy of targeting atrial fibrosis tissue during an ablation procedure treating persistent Atrial Fibrillation.

Darryl S. Wells, MD

Medtronic TAVR Low Risk

Evaluating the safety and effectiveness of the Medtronic TAVR (Transcatheter Aortic Valve Replacement) System in patients with severe aortic...

Sameer Gafoor, MD and Eric Lehr, MD

AMPLATZER AMULET Left Atrial Appendage Occluder Randomized Controlled Trial

The AmuletTM device will be evaluated for safety and efficacy by demonstrating its performance is non-inferior to the commercially available WATCHMAN® left atrial appendage closure device in patients with non-valvular atrial fibrillation.  Patients who are eligible for the trial will be randomized to receive either the Amulet device or the WATCHMAN device and will be followed for 5 years after device implant.

Sameer Gafoor, MD

GALACTIC-HF

The purpose of this study is to determine if treatment with omecamtiv mecarbil/AMG 423 when added to standard of care is well tolerated and...

John L. Mignone, MD, PhD

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder

The primary objective of this study is to demonstrate using polysomnography (PSG) that 10 mg lemborexant is superior to zolpidem tartrate extended...

Sarah Stolz, MD

STOP Persistent AF

To demonstrate safety and effectiveness of the Arctic Front Advance™ and Freezor MAX® Cardiac CryoAblation Catheters for the treatment of...

Darryl S. Wells, MD

The Chocolate Touch Study - A Randomized Trial to confirm the Safety and Effectiveness of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter in Above the Knee Lesions

The Chocolate Touch study is a randomized, multi-center, prospective, adaptive study, designed to show sufficient safety and effectiveness of the...

Paul P. Huang, MD
Viewing Page 2 of 20 | Showing Results 11 - 20 of 198